NCT05824494

Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: UNKNOWN

Phase: PHASE2

Sponsor: Women's Hospital School Of Medicine Zhejiang University

Condition: Uterine Cervical Neoplasms, Cancer of Cervix, Cervical Cancer, Cervical Neoplasms, Uterine Cervical Cancer, Cancer of the Uterine Cervix

Signal summary

Public flags

Status signal: Unknown Status Signal

Timeline signals: stale_update_signal

Results signal: Low Signal

Operational burden: rare_population_signal | strict_eligibility_signal

Stopped reason

Context when available

No stop reason available in the current public record.